X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (2628) 2628
Journal Article (1829) 1829
Newspaper Article (842) 842
Paper (709) 709
Publication (586) 586
Report (115) 115
Conference Proceeding (44) 44
Book Review (34) 34
Book / eBook (31) 31
Dissertation (27) 27
Magazine Article (18) 18
Book Chapter (16) 16
Data Set (7) 7
Compact Disc (4) 4
Reference (3) 3
Video Recording (3) 3
Streaming Audio (2) 2
Trade Publication Article (2) 2
Web Resource (2) 2
Government Document (1) 1
Poster (1) 1
Streaming Video (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (1276) 1276
performing operations (815) 815
transporting (815) 815
experiment (789) 789
chemistry (736) 736
metallurgy (725) 725
particle physics (705) 705
high energy physics - experiment (691) 691
physics - high energy physics - experiment (680) 680
human necessities (641) 641
hygiene (553) 553
medical or veterinary science (553) 553
electricity (540) 540
high energy physics (482) 482
lighting (359) 359
mechanical engineering (359) 359
heating (358) 358
blasting (356) 356
weapons (356) 356
general tagging of cross-sectional technologies spanning over several sections of the ipc (345) 345
general tagging of new technological developments (345) 345
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (345) 345
cern lhc coll (305) 305
experimental results (293) 293
organic chemistry (288) 288
phenomenology (285) 285
basic electric elements (263) 263
preparations for medical, dental, or toilet purposes (249) 249
physics of elementary particles and fields (243) 243
calculating (240) 240
computing (240) 240
counting (240) 240
testing (235) 235
measuring (233) 233
physical sciences (230) 230
fysik (229) 229
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (228) 228
nuclear experiment (221) 221
natural sciences (210) 210
naturvetenskap (210) 210
hep (189) 189
electric communication technique (182) 182
technologies or applications for mitigation or adaptation againstclimate change (182) 182
technical subjects covered by former uspc (179) 179
humans (178) 178
semiconductor devices (169) 169
physical or chemical processes or apparatus in general (168) 168
electric solid state devices not otherwise provided for (167) 167
heterocyclic compounds (165) 165
particle physics - experiment (164) 164
subatomär fysik (161) 161
p p: scattering (160) 160
subatomic physics (160) 160
electric digital data processing (158) 158
specific therapeutic activity of chemical compounds ormedicinal preparations (154) 154
index medicus (153) 153
compositions based thereon (151) 151
organic macromolecular compounds (151) 151
their preparation or chemical working-up (151) 151
p p: colliding beams (148) 148
scattering [p p] (143) 143
technical subjects covered by former us classification (142) 142
surgery (137) 137
diagnosis (133) 133
prostheses (129) 129
bandages, dressings or absorbent pads (127) 127
devices providing patency to, or preventing collapsing of,tubular structures of the body, e.g. stents (127) 127
filters implantable into blood vessels (127) 127
first-aid kits (127) 127
fomentation (127) 127
orthopaedic, nursing or contraceptive devices (127) 127
treatment or protection of eyes or ears (127) 127
13000 gev-cms (124) 124
identification (124) 124
colliding beams [p p] (119) 119
vehicles in general (119) 119
8000 gev-cms (118) 118
microbiology (113) 113
engineering elements and units (112) 112
general measures for producing and maintaining effectivefunctioning of machines or installations (112) 112
thermal insulation in general (112) 112
machine tools (111) 111
metal-working not otherwise provided for (111) 111
hadron-hadron scattering (110) 110
male (108) 108
atlas (106) 106
physics, particles & fields (106) 106
investigating or analysing materials by determining theirchemical or physical properties (105) 105
female (103) 103
beer (102) 102
engine plants in general (100) 100
machines or engines in general (100) 100
steam engines (100) 100
biochemistry (99) 99
devices for introducing media into, or onto, the body (97) 97
devices for producing or ending sleep or stupor (97) 97
devices for transducing body media or for taking media fromthe body (97) 97
enzymology (97) 97
mutation or genetic engineering (97) 97
spirits (97) 97
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (14) 14
UofT at Scarborough - Stacks (4) 4
Music - Circulation Desk (3) 3
Royal Ontario Museum - Stacks (3) 3
Thomas Fisher Rare Book - Rare Book (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Media Commons - Audio Visual (2) 2
UofT at Mississauga - Oversize (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Art - Library use only (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Robarts - Course Reserves (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
St. Michael's College (John M. Kelly) - Audio Visual (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Oversize (1) 1
UofT at Mississauga - 1st Floor (1) 1
UofT at Scarborough - Not Returned (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Victoria University E.J. Pratt - Virginia Woolf oversize (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5355) 5355
French (2579) 2579
German (1604) 1604
Spanish (28) 28
Chinese (18) 18
Danish (17) 17
Korean (3) 3
Portuguese (3) 3
Indonesian (2) 2
Italian (2) 2
Norwegian (2) 2
Serbian (2) 2
Bosnian (1) 1
Dutch (1) 1
Finnish (1) 1
Latin (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Catena, ISSN 0341-8162, 11/2016, Volume 146, pp. 147 - 154
There are many ways to measure the accomplishments of a scientist, such as papers and books published, citations, and prestige of journals published in, but we... 
Scientific contributions | Paleosols | Soil science history | Pedology | Aeolian processes | Scientific influence | REG SOILS | DESERT | WATER RESOURCES | MODEL | LOESS | SOIL SCIENCE | DUST | GEOSCIENCES, MULTIDISCIPLINARY | Career development | Scientists
Journal Article
Catena, ISSN 0341-8162, 12/2014, Volume 123, pp. 272 - 273
Journal Article
CATENA, ISSN 0341-8162, 12/2014, Volume 123, pp. 272 - 273
Journal Article
CSA News, ISSN 1529-9163, 09/2015, Volume 60, Issue 9, pp. 38 - 39
Journal Article
by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and ... and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Evidence-based medicine | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Amputation | Drug | drug therapy | chemically induced | complications | prevention & control | Peripheral Arterial Disease | etiology | Clinical Medicine | Myocardial Infarction | statistics & numerical data | blood supply | Carotid Artery Diseases | Platelet Aggregation Inhibitors | adverse effects | mortality | Lower Extremity | Dose-Response Relationship | therapeutic use | surgery
Journal Article
Europace : European pacing, arrhythmias, and cardiac electrophysiology, ISSN 1099-5129, 2018, Volume 20, Issue 5, pp. 747 - 757
Journal Article
by Connolly, Stuart J and Eikelboom, John W and Bosch, Jackie and Dagenais, Gilles and Dyal, Leanne and Lanas, Fernando and Metsarinne, Kaj and O'Donnell, Martin and Dans, Anthony L and Ha, Jong-Won and Parkhomenko, Alexandr N and Avezum, Alvaro A and Lonn, Eva and Lisheng, Liu and Torp-Pedersen, Christian and Widimsky, Petr and Maggioni, Aldo P and Felix, Camilo and Keltai, Katalin and Hori, Masatsugu and Yusoff, Khalid and Guzik, Tomasz J and Bhatt, Deepak L and Branch, Kelley R H and Cook Bruns, Nancy and Berkowitz, Scott D and Anand, Sonia S and Varigos, John D and Fox, Keith A A and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and RECH, RAFAEL and ABIB JR, EDUARDO and ... and COMPASS investigators and COMPASS Investigators and Sahlgrenska akademin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 205 - 218
Coronary artery disease is a major cause of morbidity and mortality worldwide, and is a consequence of acute thrombotic events involving activation of... 
PREVENTION | MEDICINE, GENERAL & INTERNAL | ORAL RIVAROXABAN | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Coronary Artery Disease - drug therapy | Morbidity | Factor Xa Inhibitors - therapeutic use | Factor Xa Inhibitors - adverse effects | Aged | Coronary Artery Disease - epidemiology | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Anticoagulants | Aspirin | Stroke | Heart attacks | Mortality | Coronary artery | Clinical trials | Cardiovascular disease | Coronary artery disease | Disease control | Evidence-based medicine | Disease prevention | Coronary vessels | Acute coronary syndromes | Thromboembolism | Health risk assessment | Drug therapy | Heart diseases | Cardiovascular Diseases | Factor Xa Inhibitors | Klinisk medicin | Hemorrhage | epidemiology | Rivaroxaban | administration & dosage | Combination | Drug | drug therapy | chemically induced | prevention & control | Coronary Artery Disease | Clinical Medicine | Myocardial Infarction | Platelet Aggregation Inhibitors | adverse effects | mortality | Dose-Response Relationship | therapeutic use
Journal Article